Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
Recruiting · NCT06595160 · Observational (researchers observe without assigning treatment) · Lead sponsor: Emory University
View the official record on ClinicalTrials.gov →Interventions studied
Non-Interventional Study
What this trial is about
This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- \* Age ≥ 18 years with signed informed consent form
- Patients must have a histological diagnosis of PDAC
- Resectable or borderline resectable PDAC on imaging
Exclusion criteria
- \* Patients with locally advanced and metastatic stage IV PDAC
- Patients who have already received or completed neoadjuvant chemotherapy for PDAC
- Patients with active malignancy receiving systemic therapy
Where it is running
1 location listed across 1 US state.
- Emory University Hospital/Winship Cancer Institute - Atlanta, Georgia, United States